Legend Biotech
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $272,330 | $255,058 | $195,053 | $186,522 |
Gross Profit | 157,024 | 157,067 | 123,709 | 112,600 |
EBITDA | -33,194 | -113,722 | -88,870 | 52,459 |
EBIT | -39,073 | -119,576 | -94,069 | 45,663 |
Net Income | -39,689 | -125,380 | -100,916 | 26,284 |
Net Change In Cash | 272,330 | 255,058 | 195,053 | 186,522 |
Free Cash Flow | 23,796 | -22,266 | -105,756 | -84,456 |
Cash | 278,893 | 266,586 | 441,702 | 286,749 |
Basic Shares | 92,318 | 92,067 | 91,881 | 91,425 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $627,241 | $285,143 | $117,005 | $68,826 |
Gross Profit | 392,660 | 140,929 | 51,642 | 68,826 |
EBITDA | -113,159 | -477,873 | -416,536 | -392,379 |
EBIT | -136,518 | -498,324 | -434,928 | -406,296 |
Net Income | -177,026 | -518,254 | -446,349 | -403,582 |
Net Change In Cash | 627,241 | 285,143 | 117,005 | 68,826 |
Free Cash Flow | -158,138 | -415,998 | -223,556 | -243,869 |
Cash | 286,749 | 1,277,713 | 786,031 | 688,938 |
Basic Shares | 91,425 | 88,041 | 79,520 | 70,425 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.11 |
2025-06-30 | -$0.68 |
2025-03-31 | -$0.54 |
